Page last updated: 2024-08-25

ropivacaine and Systemic Inflammatory Response Syndrome

ropivacaine has been researched along with Systemic Inflammatory Response Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, X; Dong, S; Liao, L; Liu, J; Liu, Y; Zeng, L; Zhang, T1

Trials

1 trial(s) available for ropivacaine and Systemic Inflammatory Response Syndrome

ArticleYear
Study on the protective mechanism of dexmedetomidine on the liver of perioperative diabetic patients: A randomized controlled trial.
    Medicine, 2022, Oct-14, Volume: 101, Issue:41

    Topics: Adrenergic alpha-2 Receptor Agonists; Biomarkers; Blood Glucose; Cholesterol; Dexmedetomidine; Diabetes Mellitus, Type 2; Humans; Interleukin-6; Liver; Ropivacaine; Saline Solution; Superoxide Dismutase; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2022
chemdatabank.com